These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 3016028)

  • 1. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.
    Birx DL; Redfield RR; Tosato G
    N Engl J Med; 1986 Apr; 314(14):874-9. PubMed ID: 3005862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    Tosato G; Blaese RM; Yarchoan R
    J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
    Margolick JB; Volkman DJ; Folks TM; Fauci AS
    J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
    Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
    Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody production.
    Yarchoan R; Nelson DL
    J Immunol; 1983 Sep; 131(3):1222-8. PubMed ID: 6309961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
    Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
    AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.
    Antonen J; Krohn K
    Clin Exp Immunol; 1986 Sep; 65(3):489-96. PubMed ID: 2946497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
    Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
    N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
    Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
    Kwon KW
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.